HP Shunt Product Launch at CCNS 2025: Advancing Cerebrospinal Fluid Management Solutions
WORLD SURGERY
Neurosurgical Product R&D and Manufacturer
At the recently concludedThe 19th Annual Meeting of the Chinese Neurosurgical Society (CCNS 2025)above, a series of academic feasts were held successively. As one of the key events during the annual conference, “HP Flow Diversion Product Launch Event”Successfully held on November 8 at the WORLD SURGERY exhibition hall (1F09), attracting the attention of numerous participating experts.
CCNS 2025 is a high-level academic conference in the field of neurosurgery in China, bringing together top experts and key clinical professionals from across the country. The conference focused on in-depth exchanges regarding the latest advancements, clinical challenges, and cutting-edge technologies in various subspecialties of neurosurgery, providing an authoritative platform for the dissemination of new concepts and innovations within the field.
On the occasion of this grand event, the new product launch was honored by the presence of multiple renowned experts in the field of neurosurgery in China. The site was imbued with a strong academic atmosphere, as the experts exchanged insights on novel approaches to cerebrospinal fluid management.
At the press conference, WORLD SURGERY highlighted the newly introduced products in China."HP Shunt Products"Series, designed to provide more precise and safe cerebrospinal fluid management solutions for clinical practice.
New products include:
01
Adjustable Pressure Hydrocephalus Shunt and Accessories:Equipped with multi-level precise pressure adjustment function;
02
Disposable Cerebrospinal Fluid Shunt and Accessories:Integrated anti-siphon device to help mitigate the risk of over-drainage;
03
External Ventricular Drainage System:High-capacity design with monitor connectivity to meet clinical needs for safe and efficient pressure control.
The successful holding of this press conference added a highlight to the academic exchanges at CCNS 2025. The introduction of new products is expected to inject new vitality into the clinical practice of cerebrospinal fluid management in neurosurgery in China, helping to improve the level of diagnosis and treatment.
Share
★ Add to Favorites
Like
Like